Close Menu

NEW YORK – KeyGene said today that it has extended a worldwide, non-exclusive license agreement that grants Guardant Health the right to implement certain, undisclosed, next-generation sequencing technologies for which KeyGene holds patents.

The statement comes after another announcement on April 7 that the firm had also extended an existing worldwide non-exclusive license granted to LGC Biosearch Technologies for the commercial offering and use of KeyGene's patented SBG (Sequence-Based Genotyping) technology across agricultural and life sciences applications.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.